CPAP effect on recurrent episodes in patients with sleep apnea and myocardial infarction

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1328-1335

  Garcia Rio, Francisco ^a,f   Alonso Fernández, Alberto ^b,f   Armada, Eduardo ^a   Mediano, Olga ^c   Lores, Vanesa ^d   Rojo, Blas ^e   Fernández Lahera, Juan ^a   Fernández Navarro, Isabel ^a   Carpio, Carlos ^a   Ramírez, Teresa ^e  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^c HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^d HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^e HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

CPAP; Myocardial infarction; Prognosis; Revascularization; Sleep apnea

Indexed keywords

GLUCOSE; LIPID;

ACUTE HEART INFARCTION; ADULT; APNEA HYPOPNEA INDEX; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HAZARD RATIO; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POLYSOMNOGRAPHY; POPULATION RESEARCH; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK REDUCTION; SLEEP DISORDERED BREATHING; SPIROMETRY;

CPAP; MYOCARDIAL INFARCTION; PROGNOSIS; REVASCULARIZATION; SLEEP APNEA;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYSOMNOGRAPHY; PROSPECTIVE STUDIES; RECURRENCE; SINGLE-BLIND METHOD; SLEEP APNEA SYNDROMES; TREATMENT OUTCOME;

EID: 84885320893     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.12.015     Document Type: Article

References (49)

1. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217-39.
2. Nieto FJ, Young TB, Lind BK, et al. Association of sleep disordered breathing, sleep apnea, and Hypertension In a large community-based study: Sleep Heart Health Study. JAMA 2000;283:1829-36.
3. Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation scientific Statement from the American Heart Association Council for high Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 2008;52: 686-717.
4. Peker Y, Kraiczi H, Hedner J, Löth S, Johansson A, Bende M. An Independent Association between obstructive sleep apnea and coronary artery disease. Eur Respir J 1999;14:179-84.
5. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease. Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25.
6. Nakashima H, Katayama T, Takagi C, et al. Obstructive sleep apnea Inhibits the recovery of left ventricular function In patients with acute myocardial Infarction. Eur Heart J 2006;27:2317-22.
7. Yumino D, Tsurumi Y, Takagi A, Suzuki K, Kasanuki H. Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary Intervention In patients with acute coronary syndrome. Am J Cardiol 2007;99: 26-30.
8. Lee CH, Khoo SM, Tai BC, et al. Obstructive sleep apnea In patients admitted for acute myocardial Infarction: prevalence, predictors, and effect on microvascular perfusion. Chest 2009;135:1488-95.
9. Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnoea with myocardial Infarction In men. Lancet 1990;336:261-4.
10. Moruzzi P, Sarzi-Braga S, Rossi M, Contini M. Sleep apnea In Ischemic heart disease: differences between acute and chronic coronary syndromes. Heart 1999;82:343-7.
11. Yumino D,Wang H, Floras JS, et al. Relationship between sleep apnea and mortality In patients with Ischemic heart failure. Heart 2009;95:819-24.
12. Hagenah GC, Gueven E, Andreas S. Influence of obstructive sleep apnea In coronary artery disease: a 10-year follow-up. Respir Med 2006;100:180-2.
13. Mooe T, Franklin KA, Holmström K, Rabben T,Wiklund U. Sleep-disordered breathing and coronary artery disease. Long-termprognosis.AmJ Respir Crit CareMed 2001;164: 1910-3.
14. Nakashima H, Muto S, Amenomori K, Shiraishi Y, Nunohiro T, Suzuki S. Impact of obstructive sleep apnea onmyocardial tissue perfusion In patients with ST-segment elevation myocardial Infarction. Circ J 2011;75:890-6.
15. Milleron O, Pillière R, Foucher A, et al. Benefits of obstructive sleep apnea treatment In coronary artery disease: a long-term follow-up study. Eur Heart J 2004;25:728-34.
16. Cassar A, Morgenthaler Ti, Lennon RJ, Rihal CS, Lerman A. Treatment of obstructive sleep apnea Is associated with decreased cardiac death after percutaneous coronary Intervention. J Am Coll Cardiol 2007;50:1310-4.
17. JoInt European Society of Cardiology/American College of Cardiology Committee. Myocardial Infarction redefined. A consensus document of the JoInt European Society of Cardiology/American College of Cardiology Committee for the redefinition ofmyocardial Infarction. Eur Heart J 2000;21:1502-13.
18. Duran J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features In a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 2001;163:685-9.
19. Montserrat JM, Amilibia J, Barbe F, et al. Tratamiento del síndrome de las apneas-hipopneas durante el sueño. Arch Bronconeumol 1998;34:204-6.
20. Faccenda JF, Mackay TW, Boon NA, Douglas NJ. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure In the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001;163(2):344-8.
21. Bartels NK, Börgel J, Wieczorek S, et al. Risk factors and myocardial Infarction In patients with obstructive sleep apnea: Impact of β2-adrenergic receptor polymorphisms. BMC Med 2007;5:1.
22. Grungy SM, Brewer Jr HB, Cleeman Ji, et al. Definition of metabolic syndrome: report of the National Heart, Lung, Blood Institute/Heart Association conference on scientific Issues related to definition. Circulation 2004;109:433-8.
23. Rechtschaffen A, Kales AA. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Washington, DC: Government PrInting Office; 1968 [NiH Publication No. 204].
24. The report of an AASMtask force: sleep-related breathing disorders In adults: recommendations syndrome definition and measurement techniques In clinical research. Sleep 1999;22:667-89.
25. American Sleep Disorders Association. The Atlas Task Force. EEG arousals: scoring rules and examples. Sleep 1992;15:173-84.
26. American Thoracic Society. Standardization of spirometry. 1994 UpdateAm J Respir Crit Care Med 1995;152:1107-36.
27. Quanjer PH, Trammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests. European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J 1993;6(Suppl. 16):5s-40s.
28. Lee J, Tan CS, Chia KS. A practical guide for multivariate analysis of dichotomous outcomes. Ann Acad Med Singapore 2009;38:714-9.
29. Soriano JB, Rigo F, Guerrero D, et al. high prevalence of undiagnosed airflow limitation In patients with cardiovascular disease. Chest 2010;137:333-40.
30. Peker Y,Hedner J, KraicziH, Löth S. Respiratory disturbance Index. An Independent predictor of mortality In coronary artery disease. Am J Respir Crit Care Med 2000;162: 81-6.
31. Spaak J, Egri Z, Kubo T, et al. Increased daytime muscle sympathetic nerve activity In heart failure patients with sleep apnea. Hypertension 2005;46:1327-32.
32. Alonso-Fernández A, García-Río F, Racionero MA, et al. Cardiac rhythm disturbances and ST-segment depression episodes In patients with obstructive sleep apnea-hypopnea syndrome and Its mechanisms. Chest 2005;127:15-22.
33. Yamauchi M, Nakano H, Maekawa J, et al. Oxidative stress In obstructive sleep apnea. Chest 2005;127:1674-9.
34. Barcelo A, Barbe F, de la PenaM, et al. Antioxidant status In patients with sleep apnoea and Impact of continuous positive airway pressure treatment. Eur Respir J 2006;27: 756-60.
35. Jelic S, PadelettiM, Kawut SM, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium In obstructive sleep apnea. Circulation 2008;117: 2270-8.
36. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species In leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002;165:934-9.
37. von Kanel R, Dimsdale JE. Hemostatic alterations In patients with obstructive sleep apnea and the Implications for cardiovascular disease. Chest 2003;124: 1956-67.
38. Savransky V, Nanayakkara A, Li J, et al. Chronic Intermittent hypoxia Induces atherosclerosis. Am J Respir Crit Care Med 2007;175:1290-7.
39. Hayashi M, Fujimoto K, Urushibata K, Uchikawa Si, Imamura H, Kubo K. Nocturnal oxygen desaturation correlates with the severity of coronary atherosclerosis In coronary artery disease. Chest 2003;124:936-41.
40. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA. Early expression of angiogenesis factors In acute myocardial Ischemia and Infarction. N Engl J Med 2000;342:626-33.
41. Lavie P, Lavie P. Ischemic preconditioning as a possible explanation for the age decline relative mortality In sleep apnea. Med Hypotheses 2006;66:1069-73.
42. Steiner S, Schueller PO, Schulze V, Strauer BE. Occurrence of coronary collateral vessels In patients with sleep apnea and total coronary occlusion. Chest 2010; 137:516-20.
43. Cheema AN, Hong T, Nili N, et al. Adventitial microvessel formation after coronary stenting and the effects of SU11218, a tyrosine kinase Inhibitor. J Am Coll Cardiol 2006;47:1067-75.
44. Sluimer JC, Gasc JM, van Wanroij JL, et al. Hypoxia, hypoxia Inducible transcription factor, and macrophages In human atherosclerotic plaques are correlated with Intraplaque angiogenesis. J Am Coll Cardiol 2008;51:1258-65.
45. Alonso-Fernández A, García-Río F, Arias MA, et al. Effects of CPAP on oxidative stress and nitrate efficiency In sleep apnoea: a randomised trial. Thorax 2009; 64:581-6.
46. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and Interleukin-6 In patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107:1129-34.
47. Arias MA, García-Río F, Alonso-Fernández A, et al. CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 In obstructive sleep apnoea. Eur Respir J 2008;32:1009-15.
48. Cross MD, Mills NL, Al-Abri M, et al. Continuous positive airway pressure Improves vascular function In obstructive sleep apnoea/hypopnoea syndrome: a randomised controlled trial. Thorax 2008;63:578-83.
49. Wang H, Parker JD, Newton GE, et al. Influence of obstructive sleep apnea on mortality In patients with heart failure. J Am Coll Cardiol 2007;49:1625-31.